Haemonetics (HAE) announces CSL has informed it of its intent not to renew its Supply Agreement

Go back to Haemonetics (HAE) announces CSL has informed it of its intent not to renew its Supply Agreement

Haemonetics Provides Update On U.S. Plasma Business

April 19, 2021 6:00 AM EDT

BOSTON, April 19, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics" or the "Company"), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that CSL Plasma, Ltd. ("CSL") has informed Haemonetics of its intent not to renew its Supply Agreement with Haemonetics for the use of PCS2® Plasma Collection System devices and the purchase of disposable plasmapheresis kits in the U.S. following the expiration of the current term in June 2022. Haemonetics was informed that the decision was based on changes in... More